Cargando…
A 63 element 1.75 dimensional ultrasound phased array for the treatment of benign prostatic hyperplasia
BACKGROUND: Prostate cancer and benign prostatic hyperplasia are very common diseases in older American men, thus having a reliable treatment modality for both diseases is of great importance. The currently used treating options, mainly surgical ones, have numerous complications, which include the m...
Autores principales: | Saleh, Khaldon Y, Smith, Nadine Barrie |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1175852/ https://www.ncbi.nlm.nih.gov/pubmed/15963237 http://dx.doi.org/10.1186/1475-925X-4-39 |
Ejemplares similares
-
Additive effect of oral LDD175 to tamsulosin and finasteride in a benign prostate hyperplasia rat model
por: Choi, Bo Ram, et al.
Publicado: (2018) -
Three-dimensional measurement and analysis of benign prostatic hyperplasia
por: Feng, Yankun, et al.
Publicado: (2021) -
Benign Prostatic Hyperplasia
Publicado: (2015) -
Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015) -
Clinical application of contrast enhanced ultrasound to diagnose benign prostatic hyperplasia
por: Shi, Jingfang, et al.
Publicado: (2014)